Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NWRD09 in HPV16-Positive Cervical HSIL
NCT07712692Phase 2Not yet recruiting
- Sponsor
- Newish Biotechnology
- Start
- Aug 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of NWRD09 in Squamous Intraepithelial Lesion (SIL), sponsored by Newish Biotechnology. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
NWRD09
03
Conditions
Squamous Intraepithelial Lesion (SIL)
Beyond the preview
Go deeper on NCT07712692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07712692.